Phio Pharmaceuticals Corp...

NASDAQ: PHIO · Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.12
-4.07%
After-hours: Aug 15, 2025, 05:02 PM EDT

Phio Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.38M 8.49M 11.78M 24.06M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 3K 24K 27K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
354K 832K 665K 50K
Total Current Assets
5.74M 9.32M 12.45M 24.73M
Property-Plant & Equipment
2K 39K 344K 416K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2K 42K 368K 443K
Total Assets
5.74M 9.36M 12.81M 25.17M
Account Payables
253K 657K 779K 283K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 135K 125K
Other Current Liabilities
731K 720K 482K 1.96M
Total Current Liabilities
1.01M 1.63M 1.8M 3.07M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 2K n/a
Total Long-Term Liabilities
n/a n/a 172K 170K
Total Liabilities
1.01M 1.63M 1.98M 3.24M
Total Debt
n/a 35K 305K 295K
Common Stock
n/a n/a n/a 1K
Retained Earnings
-146.36M -139.21M -128.38M -116.9M
Comprehensive Income
n/a -0.00 n/a 0.00
Shareholders Equity
4.72M 7.73M 10.84M 21.93M
Total Investments
n/a n/a n/a n/a